Mar 04, 2021 / 04:10PM GMT
Ritu Subhalaksmi Baral - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Hi, everyone. Thanks for joining us today at the last day of the Cowen Healthcare Conference in 2021. And thanks for joining us for the NGM fireside chat. I'm covering analyst Ritu Baral. And with us from NGM today, we have CEO David Woodhouse; and CFO, Siobhan Mangini. Thanks, guys, for joining us.
David J. Woodhouse - NGM Biopharmaceuticals, Inc. - CEO & Director
Thanks for the invite. We're always happy to attend the Cowen conference whether virtual or in-person.
Ritu Subhalaksmi Baral - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology Analyst
Yes. So well, hopefully, this is the last virtual. And hope to see everybody in the fall for their conference for those clients on the line.
Questions and Answers:
Ritu Subhalaksmi Baral - Cowen and Company, LLC, Research Division - MD & Senior Biotechnology AnalystSo let's start with,